Molecule Details
| InChIKey | SBMRIYCGYSYWIJ-OMEPFRQKSA-N |
|---|---|
| Compound Name | 4-[[(2S)-1-[[(2S)-1-[[2-[[(2R)-1-[[(2S)-1-[[(1R)-1-[[(2S)-3-amino-2-benzyl-3-oxopropanoyl]amino]-2-carboxyethyl]amino]-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoic acid |
| Canonical SMILES | CCCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)C(CC(=O)O)NC(=O)OC(C)(C)C)C(=O)NCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCC)C(=O)N[C@H](CC(=O)O)NC(=O)[C@@H](Cc1ccccc1)C(N)=O |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.0 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile